Order byBest matchMost fresh

Walgreens beats on revenue in 1 of its last earnings reports

Digest more
Top News
Impacts
Fast Company |
Shares in Walgreens Boots Alliance, Inc. (Nasdaq: WBA) are trading slightly higher this morning after the company reported its Q2 2025 earnings results.
Wall Street Journal |
The pharmacy chain narrowed its loss to $2.85 billion, or $3.30 a share, for the second quarter ended Feb. 28, from $5.91 billion, or $6.85 a share, in the prior-year period.

Read more on News Digest

WBA stock price: Walgreens beats on revenue in one of its last earnings reports as a public company
Walgreens had previously said in January that it had expected a full-year 2025 EPS of between $1.40 and $1.80 per share. However, in its press release for its Q2, Walgreens stated that “WBA’s previously issued guidance for full year fiscal 2025 should no longer be relied upon.”
Walgreens Boots Alliance (WBA) Beats Q2 Earnings and Revenue Estimates
Walgreens Boots Alliance (WBA) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.53 per share. This compares to earnings of $1.20 per share a year ago. These figures are adjusted for non-recurring items.
Should You Buy Walgreens Boots Alliance Stock Before It Goes Private?
The equity value of the deal is approximately $10 billion, with Sycamore paying $11.45 per share for Walgreens. There is also a possibility for shareholders to get up to an extra $3 per share if Sycamore sells the company's primary care operations, which include Village MD.
Walgreens Sales Rise on U.S. Retail Pharmacy Segment Growth
Walgreens Boots Alliance posted higher sales in its latest quarter on growth in retail-pharmacy sales in the U.S., in one of the last quarterly reports the company will publicly file ahead of its transition to a private company.
Walgreens: Fiscal Q2 Earnings Snapshot
The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 53 cents per share. The largest U.S. drugstore chain posted revenue of $38.59 billion in the period, which also topped Street forecasts.
Walgreens takes another $2B hit on VillageMD investment
A goodwill impairment charge acts as a noncash write-off on the balance sheet to show when an investment hasn't performed as expected. The latest charge is in addition to a nearly $6 billion hit related to VillageMD in the second quarter of the company's fiscal 2024,
Stocks set to surge, Levi's & Walgreens earnings: 3 Things
Here are three stories Wall Street is watching ahead of the market open. All three of the major averages (ES=F, NQ=F, YM=F) are set to surge at the open as hopes grow for trade deals, despite President Trump insisting that his new tariffs will go into effect tomorrow.
Top Wall Street Forecasters Revamp Walgreens Price Expectations Ahead Of Q2 Earnings
Analysts expect the company to report quarterly earnings at 53 cents per share, down from $1.2 per share in the year-ago period. According to data from Benzinga Pro, Walgreens projects quarterly revenue at $38.0 billion, compared to $37.05 billion a year earlier.
Investing2d
Walgreens beats profit estimates ahead of Sycamore Partners deal
(Reuters) -Walgreens, which is in the process of being taken private by Sycamore Partners, beat Wall Street estimates for quarterly profit as the pharmacy chain operator benefited from a ...
Feedback